Institut Curie-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Institut Curie - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014094
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institut Curie is a cancer research foundation that operates cancer research institutes and hospitals and concentrates on the developing new treatments for cancer. The foundation carries out research in the areas of immunology, pharmachemistry, bioinformatics and systems biology, cell biology and developmental biology, genetics and carcinogenesis, cell and tissue imaging, and others. It provides care, research and training services for detecting, treating and monitoring cancer. Institut Curie offers services in anesthesia, medicine, pediatrics, surgery, tumor biology, intensive care, pain, medical imaging, and others. The foundation provides masters, PhD and postdoctoral fellowship programmes and other courses. Institut Curie is headquartered in Paris, France.

Institut Curie – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institut Curie, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Curie, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Curie, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Curie, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Curie, Medical Devices Deals, 2011 to YTD 2017 9
Institut Curie, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Institut Curie, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Institut Curie Enters into Agreement with Pierre Fabre 11
Celyad Enters into Partnership with Institut Curie 12
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 13
Curie-Cancer Partners with Inventiva 14
Institut Curie Extends Research Agreement With Servier To Develop Breast Cancer Treatments 15
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 16
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 17
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 18
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 19
Licensing Agreements 20
Theravectys Enters into Licensing Agreement with Institut Curie 20
Abbott Molecular Enters into Licensing Agreement with Institut Curie 21
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 22
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 23
Institut Curie – Key Competitors 24
Institut Curie – Key Employees 25
Institut Curie – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Government and Public Interest 27
May 13, 2016: Cervical Cancer And The HPV Virus: A New Tool For Understanding Tumour Diversity 27
May 13, 2016: HIV: Entry Keys Discovered in the Cell Nucleus 28
May 13, 2016: Breast Cancer: Blocking The First Steps in Tumour Invasion 29
May 13, 2016: Cervical Cancer: Initial Results from a European Study 30
Product News 31
Oct 17, 2016: Leukaemia: discovery of an interrupter that causes the death of tumorous cells 31
Jun 24, 2016: Uveal Melanoma: A Promising Avenue for Treating Metastatic Forms 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Institut Curie, Pharmaceuticals & Healthcare, Key Facts 2
Institut Curie, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Institut Curie, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Institut Curie, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Institut Curie, Deals By Therapy Area, 2011 to YTD 2017 8
Institut Curie, Medical Devices Deals, 2011 to YTD 2017 9
Institut Curie, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Institut Curie Enters into Agreement with Pierre Fabre 11
Celyad Enters into Partnership with Institut Curie 12
Curie-Cancer Extends Co-Development Agreement with GamaMabs Pharma 13
Curie-Cancer Partners with Inventiva 14
Institut Curie Extends Research Agreement With Servier To Develop Breast Cancer Treatments 15
Curie-Cancer Enters into Co-Development Agreement with GamaMabs Pharma 16
Institut Curie Enters Into Research Agreement With Sanofi To Develop Ovarian Cancer Treatments 17
Curie-Cancer And GenoSplice Form Bioinformatics Partnership For Cancer Genomics 18
Curie-Cancer Enters Into Research Agreement With Harmonic Pharma 19
Theravectys Enters into Licensing Agreement with Institut Curie 20
Abbott Molecular Enters into Licensing Agreement with Institut Curie 21
Meiogenix Enters Into Licensing Agreement With Curie-Cancer And Institut National de la Recherche Agronomique 22
Floralis Enters into Licensing Agreement with Ecrins Therapeutics 23
Institut Curie, Key Competitors 24
Institut Curie, Key Employees 25

★海外企業調査レポート[Institut Curie-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Glorious Sun Enterprises Limited (393):企業の財務・戦略的SWOT分析
    Glorious Sun Enterprises Limited (393) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Windflow Technology Limited (WTL):企業の財務・戦略的SWOT分析
    Windflow Technology Limited (WTL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sumitomo Mitsui Trust Holdings Inc
    Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Tosoh Bioscience Inc:企業の製品パイプライン分析2018
    Summary Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, ß-thalassemia testing, and HPLC technology. Its immunoassay solutions compri …
  • Nielsen Holdings plc (NLSN):企業の財務・戦略的SWOT分析
    Nielsen Holdings plc (NLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • EnPro Industries Inc (NPO):企業の財務・戦略的SWOT分析
    Summary EnPro Industries Inc (EnPro) is a diversified company that offers engineering solutions. The company designs, develops, manufactures and markets proprietary engineered industrial products. It provides commercial vehicle wheel-end components. EnPro offers sealing solutions for a wide range of …
  • Fcmb Group Plc:企業の戦略・SWOT・財務分析
    Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report Summary Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Indian Bank:企業の戦略・SWOT・財務情報
    Indian Bank - Strategy, SWOT and Corporate Finance Report Summary Indian Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Optimum General Inc.
    Optimum General Inc. - Strategy, SWOT and Corporate Finance Report Summary Optimum General Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Superior Energy Services, Inc.:企業の戦略・SWOT・財務情報
    Superior Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Genting Singapore Plc:戦略・SWOT・企業財務分析
    Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report Summary Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Acelity Holdings, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Acelity Holdings Inc (Acelity) is a medical technology company engaged in developing wound care and regenerative medicine solutions. The company offers various solutions such as incision management, open abdomen management, epidermal harvesting and animal health. Acelity through its subsidia …
  • New World Development Company Limited:企業の戦略・SWOT・財務分析
    New World Development Company Limited - Strategy, SWOT and Corporate Finance Report Summary New World Development Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Cubic Corp (CUB):企業の財務・戦略的SWOT分析
    Cubic Corp (CUB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • HRG Group, Inc. (HRG):企業の財務・戦略的SWOT分析
    HRG Group, Inc. (HRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ferno-Washington Inc:企業の戦略的SWOT分析
    Ferno-Washington Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • GATT Technologies BV:企業の製品パイプライン分析2018
    Summary GATT Technologies BV (GATT Technologies) is a medical technology company which develops synthetic surgical hemostat and sealant products that control severe bleeding. Its product pipeline includes GATT-Patch for controlling excessive bleeding; GATT-Tape for blocking intestinal anastomotic le …
  • TenneT Holding BV:電力:M&Aディール及び事業提携情報
    Summary TenneT Holding BV (TenneT), owned by the Ministry of Finance of The State of the Netherlands, is an electricity transmission system operator. The company offers electricity transmission and system services. It constructs and maintains high voltage grid to transmit electricity from the produc …
  • Evraz Plc:企業の戦略・SWOT・財務情報
    Evraz Plc - Strategy, SWOT and Corporate Finance Report Summary Evraz Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆